News Article | April 17, 2017
Philanthropy is an understated affair at Glenwood Hot Springs where giving back is as natural as the hot springs themselves. Healing and rejuvenating are two words that are often used to describe the geothermal water at Glenwood Hot Springs, the world’s largest mineral hot springs pool; those words also underscore the resort’s commitment to improving the lives of individuals out of the water. Glenwood Hot Springs supports a diverse group of organizations that help all kinds of people, though you wouldn’t know it because the resort’s management likes to keep its charitable giving on the down low. “Glenwood Hot Springs doesn’t toot its own horn when it comes to philanthropy,” said Jeremy Gilley, Director of Sales and Revenue for Glenwood Hot Springs and the Spa of the Rockies. “Management quietly goes about making donations and supporting groups without making a big fuss about it. We recently revised our media kit and I looked at the list of charitable donations and thought, wow, I bet people would love to know about this,” said Gilley. Gilley sold the idea to management which reluctantly agreed to the writing of this blog post about its community-oriented good works. “Philanthropic giving is just something they do. It’s an integral part of their DNA and their corporate philosophy,” said Gilley, explaining management’s tendency to shy away from publicity on this topic. “I think it’s worth noting however, that Glenwood Hot Springs through many organizations has helped countless people over the years, from young students to injured war veterans.” Some of the largest contributions have gone to Valley View Hospital Foundation to help fund the Heart and Vascular Center and the Glenwood Springs Whitewater Recreation Area. In addition to hundreds of in-kind donations in the form of pool passes, spa treatments and overnight accommodations, Glenwood Hot Springs donates thousands of dollars per year to a variety of causes. Some organizations that stand out are Lift-Up, YouthZone, Summer of Music concerts and Special Olympics, as well as service groups like the Lions, Rotary and Kiwanis Clubs. Glenwood Hot Springs is also a strong supporter of youth and education. Every year, it makes contributions to numerous youth-oriented groups such as Boy Scouts, Girl Scouts and high school programs like Mock Trial. Rather than throwing away gently-used or outdated fitness gear and equipment, the Glenwood Hot Springs Athletic Club donates these items to the Athletic Department at Glenwood Springs High School for students to use as part of the school’s physical education program. Glenwood Hot Springs also funds annual scholarships for deserving high school students to pursue their higher education goals. Glenwood Hot Springs has supported and continues to contribute to a number of worthy causes including the following: Find out more about Glenwood Hot Springs at www.hotspringspool.com.
News Article | May 5, 2017
-- On Thursday, April 27th, representatives from the Health Policy Commission presented $425,000 in funding for Heywood Healthcare to implement new School Based TeleBehavioral Health Services to address the existing behavioral health needs and the gaps in care for the North Central and North Quabbin region, in particular for youth and children.This collaborative model will leverage interactive video conferencing technology to increase access to behavioral health services for school aged children and their families in a convenient and non-threatening setting. The project is a partnership between Heywood Healthcare, Narragansett Regional and Ralph C. Mahar Regional School Districts in partnership with Clinical Support Options, Northeast Telehealth Resource Center and Mclean Hospital.Heywood Healthcare's new TeleBehavioral Health model shifts the traditional model of behavioral health treatment from being isolated in clinical settings to the community, reaching children in a familiar setting where there is a support system. Behavioral Health services will now be directly accessed in the school, breaking down barriers by offering timely access, lower costs, and reduced time constraints, while filling service gaps inherent in rural areas.This collaborative venture has gained support at the State House, as well. Senator Anne Gobi sees this new venture of positively impacting area youth. "Having the ability to make sure people in our more rural areas are able to access health care is a necessity," she stated. "This grant is critical piece in providing services. I appreciate all that Heywood Healthcare has done and continues to do for our region"Additionally, Representative Susannah Whipps agrees the implementation of tele-health services can enhance the health and wellbeing of the entire region. "This grant will help allow local residents, who choose to live in our beautiful rural region, to access behavioral health services around the world to get the care they need and deserve." Representative Whipps thanks the Health Policy Commission for recognizing the need for these important services and Heywood Healthcare for being a leader in providing quality services to our region."Massachusetts is home to some of the most creative, forward-thinking health care leaders in the world. This unique initiative from Heywood Healthcare will increase access to behavioral health services by integrating telemedicine technology directly into schools to address a current unmet need," said David Seltz, HPC Executive Director. "This award promotes the HPC's commitment to transformation and innovation in our health care system. We look forward to continuing to partner with Heywood Healthcare and the communities it serves to build a more coordinated and affordable health care system.""Heywood Healthcare is steadfast in our commitment to improving access to healthcare services," shared Dawn Casavant, Vice President of Philanthropy and External Affairs for Heywood Healthcare. Early identification and access to behavioral health services are pivotal to the health and well-being of our region's youth, and we are grateful for the support of the Health Policy Commission, and the willingness of our local school districts to work in partnership to bridge existing gaps in care."For more information on the TeleBehavioral Health grant and the programs it supports, please contact Maureen Donovan, Project Manager, at (978) 249-3703.###About Athol HospitalA member of the Heywood Healthcare system, Athol Hospital is a 25-bed non-profit, acute care and outpatient facility serving the communities of the North Quabbin region of Massachusetts. Athol Hospital's services include 24/7 Emergency Care, Oncology, Radiology and Laboratory, Diabetes Center and Center for Skilled Nursing and Rehabilitation. It is designated as a Critical Access Hospital and Primary Stroke Center, licensed by the Massachusetts Department of Public Health and accredited by the Joint Commission.About Heywood HospitalA member of the Heywood Healthcare system, Heywood Hospital is a 134-bed acute care hospital in Gardner, MA, which provides a broad range of high quality medical, surgical, obstetrical, pediatric and behavioral health services on an inpatient and outpatient basis. The hospital's Centers of Excellence include the Watkins Center for Emergency and Acute Care; the LaChance Maternity Center; the Diabetes Center; and the Heywood Heart and Vascular Center, an affiliate of the Heart and Vascular Center of Excellence at UMass Memorial Health Care.About Heywood HealthcareHeywood Healthcare is an independent, community-owned healthcare system serving north central Massachusetts and southern New Hampshire. It is comprised of Heywood Hospital, a non-profit, 134-bed acute-care hospital in Gardner, MA; Athol Hospital, a 25-bed not-for-profit, Critical Access Hospital in Athol, MA; the Quabbin Retreat in Petersham, MA; and Heywood Medical Group with primary care physicians and specialists located throughout the region. The organization includes six satellite facilities in MA; Heywood Rehabilitation Center and Heywood Urgent Care in Gardner; West River Health Center in Orange; Winchendon Health Center and Murdock School-based Health Center in Winchendon; Heywood Charitable Foundation; the North Quabbin Community Coalition, an affiliate organization;and The Quabbin Retreat in Petersham.About the Health Policy CommissionThe Health Policy Commission (HPC) is an independent state agency established through Chapter 224 of the Acts of 2012, the Commonwealth's landmark health care cost containment law. The HPC, led by an 11-member Board with diverse experience in health care, is charged with developing health policy that reduces overall cost growth while improving the quality of care, and monitoring the health care delivery and payment systems in Massachusetts. The HPC's mission is to advance a more transparent, accountable, and innovative health care system through its independent policy leadership and investment programs. Visit us at Mass.gov/HPC. Tweet us @Mass_HPC
News Article | March 3, 2017
ORANGE, CA, March 03, 2017 /24-7PressRelease/ -- St. Joseph Hospital's Kidney Transplant Center is the only kidney transplant program in Orange County and one of just four in California to earn the highest "5" rating from the Scientific Registry of Transplant Recipients (SRTR), according to a recently released report. In addition, the kidney transplant program at St. Joseph Hospital in Orange has had the highest three-year success rate for patients in the state of California for the past 10 consecutive years. The one-to-five rating is based on an extensive analysis of one year transplant success rates over the course of the previous 2 ½ years. Only 30 kidney transplant programs in the United States earned a "5" rating. SRTR was created by Congress in the 1980s to collect, analyze and report data on every transplant performed in the United States. It has since become one of the largest medical databases in the world. "St. Joseph Hospital has a long history of providing excellent care for our patients, and we're honored to be recognized as one of the best for the work we do in transplantation," said Ervin Ruzics, MD, Medical Director of the Kidney Transplant Center at St. Joseph Hospital. "We take our calling seriously, and we strive for perfection every day, for every patient." The ratings, called outcome assessments, are risk-adjusted scores evaluating how often patients are thriving with a functioning transplanted organ one year after the procedure. According to data released earlier this year by the United Network for Organ Sharing, 33,606 organ transplants were reported in the United States, a record high for the fourth consecutive year. There has been a nearly 20 percent increase in transplantations since 2012. For more information on St. Joseph Hospital's Kidney Transplant Center, please visit: http://www.sjo.org/Our-Services/Kidney-Transplant-Center.aspx. About St. Joseph Hospital Founded in 1929, St. Joseph Hospital in Orange, California is a nationally recognized, 463-bed, not-for-profit Catholic hospital dedicated to extending the healing ministry of Jesus in the tradition of the Sisters of St. Joseph of Orange. Fully accredited by The Joint Commission and designated as a Magnet hospital for nursing excellence, St. Joseph Hospital's reputation for clinical excellence and compassionate, family-centered care draws patients from all over the United States. This is one reason why St. Joseph Hospital was named one of the top hospitals in the Los Angeles/Orange County area by U.S. News & World Report. With a highly recognized 1,000-member medical staff and more than 3,100 support staff, St. Joseph Hospital is home to more than 75 specialty programs, including The Center for Cancer Prevention and Treatment, the Heart and Vascular Center and a nationally acclaimed Orthopedics program that has been ranked among the top 50 in the nation by U.S.News & World Report. Equally important is St. Joseph Hospital's dedication to caring for the medically underserved through health education programs, a free-standing medical and dental clinic, and mobile health vans. St. Joseph Hospital depends on philanthropic support from the community to carry out its mission. These efforts are coordinated through the St. Joseph Hospital Foundation. St. Joseph Hospital is a member of the Irvine-based St. Joseph Hoag Health alliance, an integrated health network of seven hospitals, 26 urgent care centers and an array of programs and services throughout Orange County and the High Desert.
Richardson Dr. K.,Heart and Vascular Center |
Schoen Dr. M.,Heart and Vascular Center |
Arnold Dr. S.E.,Penn Memory Center |
Heidenreich Dr. P.A.,Veterans Affairs Palo Alto Medical Center |
And 2 more authors.
Annals of Internal Medicine | Year: 2013
Background: Despite the U.S. Food and Drug Administration (FDA) warning regarding cognitive impairment, the relationship between statins and cognition remains unknown. Purpose: To examine the effect of statins on cognition. Data Sources: PubMed, Embase, and Cochrane Library from inception through October 2012; FDA databases from January 1986 through March 2012. Study Selection: Randomized, controlled trials (RCTs) and cohort, case-control, and cross-sectional studies evaluating cognition in patients receiving statins. Data Extraction: Two reviewers extracted data, 1 reviewer assessed study risk of bias, and 1 reviewer checked all assessments. Data Synthesis: Among statin users, low-quality evidence suggested no increased incidence of Alzheimer disease and no difference in cognitive performance related to procedural memory, attention, or motor speed. Moderate-quality evidence suggested no increased incidence of dementia or mild cognitive impairment or any change in cognitive performance related to global cognitive performance scores, executive function, declarative memory, processing speed, or visuoperception. Examination of the FDA postmarketing surveillance databases revealed a low reporting rate for cognitive-related adverse events with statins that was similar to the rates seen with other commonly prescribed cardiovascular medications. Limitations: The absence of many well-powered RCTs for most outcomes resulted in final strengths of evidence that were low or moderate. Imprecision, inconsistency, and risk of bias also limited the strength of findings. Conclusion: Larger and better-designed studies are needed to draw unequivocal conclusions about the effect of statins on cognition. Published data do not suggest an adverse effect of statins on cognition; however, the strength of available evidence is limited, particularly with regard to high-dose statins. © 2013 American College of Physicians.
News Article | February 23, 2017
LA JOLLA, CA - February 22, 2017 - The MagnaSafe Registry, a new multicenter study led by scientists at The Scripps Research Institute (TSRI), has demonstrated that appropriately screened and monitored patients with standard or non-MRI-conditional pacemakers and defibrillators can undergo MRI at a field strength of 1.5 tesla without harm. These devices are not presently approved by the U.S. Food and Drug Administration (FDA) for MRI scanning. The researchers observed no patient deaths, device or lead failures, losses of pacing function or ventricular arrhythmias in 1,500 patients who underwent MRI using a specific protocol for device interrogation, device programming, patient monitoring and follow-up designed to reduce the risk of patient harm from MRI effects. The research will be published as an Original Article in the February 23, 2017 issue of The New England Journal of Medicine. The use of MRI poses potential safety concerns for patients with an implanted cardiac device. These concerns are a result of the potential for magnetic field-induced cardiac lead heating, which could result in cardiac injury and damage to an implanted device. As a result, it has long been recommended that patients with a pacemaker or defibrillator not undergo MRI scanning, even when MRIs are considered the most appropriate diagnostic imaging method for their care. Despite the development of devices designed to reduce the potential risks associated with MRI, a large number of patients have devices that have not been shown to meet these criteria and are considered "non-MRI-conditional." At least half these patients are predicted to have the need for MRI after a device has been implanted. Researchers established the MagnaSafe Registry to determine the frequency of cardiac device-related events among patients with non-MRI-conditional devices, as well as to define a simplified protocol for screening, monitoring and device programming before MRI. "Given the great clinical demand for MRI for patients with a standard pacemaker or defibrillator, we wanted to determine the risk," said study leader Dr. Robert Russo, an adjunct professor at TSRI and director of The La Jolla Cardiovascular Research Institute. In the MagnaSafe Registry, researchers at 19 U.S. institutions tested 1,000 cases with a non-MRI-conditional pacemaker (one not approved for use in an MRI) and 500 cases of patients with a non-MRI-conditional implantable cardioverter defibrillator (ICD), a device that can shock the heart in response to a potentially fatal cardiac rhythm. They scanned regions other than the chest, such as the brain, spine or extremities--where MRI is traditionally the best option for imaging. The researchers tested the devices at an MRI field strength of 1.5 tesla, a standard strength for MRI scanners and reprogrammed some devices according to a prespecified protocol for the MRI examination. "If the patient was not dependent upon their pacemaker, the device was turned off," explained Russo. "If they could not tolerate having the device turned off, it was set to a pacing mode that did not sense cardiac activity. The reason was that the pacemaker could sense the electrical activity (radiofrequency energy) from the MRI scanner and the function of the device could be inhibited, which could be catastrophic if you depend upon your pacemaker for your heartbeat." Russo and his co-investigators did observe adverse effects in a small group of patients. Six patients had a brief period of atrial fibrillation, and in six additional cases pacemaker partial reset (a loss of stored patient information) was noted. But in no cases did the researchers observe device failure or a failure in the leads that connect the device to the heart when the protocol was followed. "One ICD generator could not be interrogated after MRI and required immediate replacement; the device had not been appropriately programmed per protocol before the MRI," explained Russo. These findings led the researchers to conclude that "device removal and replacement seem unlikely to be safer than proceeding with scanning for patients with a pacemaker or an ICD who require a nonthoracic MRI," provided a protocol similar to the MagnaSafe protocol was followed. "Patients with a standard or non-MRI-conditional pacemaker can undergo clinically indicated MRI without harm if a protocol such as the 'MagnaSafe' protocol used in this study is followed and patients are screened and monitored as described," said Russo. The researchers also noted that their results may not be predictive of findings with all device and lead combinations, higher MRI field strengths, patients younger than 18 years of age and MRI examinations of the chest or cardiac resynchronization devices (those designed to increase the function of a failing heart). The researchers plan to follow up by studying the risk for patients in need of a chest scan at scanner field strength of 1.5 tesla, as well as an MRI of any anatomic area at a higher field strength (3.0 tesla). The study, "Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator," also included authors from the University of California, San Diego; Scripps Memorial Hospital; the University of California, Los Angeles; Providence St. Joseph Medical Center; the University of Arizona; Intermountain Medical Center; Inova Heart and Vascular Institute; Allegheny General Hospital; Abington Memorial Hospital; Yale University School of Medicine; Providence Heart Institute; Oklahoma Heart Institute; the University of Mississippi Medical Center; the Medical College of Wisconsin; Bassett Medical Center; Carnegie Hill Radiology; Methodist DeBakey Heart and Vascular Center and Baptist Health. The study was supported by grants from St. Jude Medical, Biotronik, Boston Scientific and the Hewitt Foundation for Medical Research, and by philanthropic gifts from Mr. and Mrs. Richard H. Deihl, Evelyn F. and Louis S. Grubb, Roscoe E. Hazard, Jr. and the Shultz Steel Company. The Scripps Research Institute (TSRI) is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. TSRI is internationally recognized for its contributions to science and health, including its role in laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, the institute now employs more than 2,500 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientists--including two Nobel laureates and 20 members of the National Academies of Science, Engineering or Medicine--work toward their next discoveries. The institute's graduate program, which awards PhD degrees in biology and chemistry, ranks among the top ten of its kind in the nation. In October 2016, TSRI announced a strategic affiliation with the California Institute for Biomedical Research (Calibr), representing a renewed commitment to the discovery and development of new medicines to address unmet medical needs. For more information, see http://www. .
News Article | November 29, 2016
CHICAGO - Researchers using coronary computed tomography angiography (CCTA) have found no association between light to moderate alcohol consumption and coronary artery disease (CAD), according to a study being presented today at the annual meeting of the Radiological Society of North America (RSNA). Some previous studies have suggested that light alcohol consumption may actually reduce the risk for CAD. However, data regarding regular alcohol consumption and its association with the presence of CAD remains controversial. For the new study, researchers looked at alcohol consumption, type of alcohol consumed, and presence of coronary plaques using CCTA. "CCTA is an excellent diagnostic modality to noninvasively depict the coronary wall and identify atherosclerotic lesions," said study author Júlia Karády, M.D., from the MTA-SE Cardiovascular Imaging Research Group, Heart and Vascular Center at Semmelweis University in Budapest, Hungary. "Furthermore, we're able to characterize plaques and differentiate between several types. Prior studies used cardiovascular risk factors--like high cholesterol levels--and cardiovascular outcomes to study the effects of alcohol, but our study is unique in that we analyzed both drinkers and non-drinkers using CCTA, which may shed some light on how alcohol may or may not contribute to the development of fatty plaques in the arteries of the heart." The researchers studied 1,925 consecutive patients referred for CCTA with suspected CAD. Information on alcohol consumption habits was collected using questionnaires about the amount and type of alcohol consumed. Using an in-house reporting platform that contained the patients' clinical and CCTA data, researchers were able to assess the relationship between atherosclerosis, clinical risk factors and patient drinking habits. "About 40 percent of our patients reported regular alcohol consumption, with a median of 6.7 alcohol units consumed weekly," Dr. Karády said. One unit translates to approximately 2 deciliters (dl) or 6.8 fluid ounces of beer, 1 dl or 3.4 ounces of wine, or 4 centiliters (cl) or 1.35 ounces of hard liquor. The results showed that the amount of weekly alcohol consumption, whether light or moderate, was not associated with the presence of CAD. In addition, when researchers looked at different types of alcohol and the presence of coronary atherosclerosis, no associations were found. "When we compared consumption between patients who had coronary artery plaques and those who had none, no difference was detected," Dr. Karády said. "Evaluating the relationship between light alcohol intake (maximum of 14 units per week) and presence of CAD, we again found no association. Furthermore, we analyzed the effect of different types of alcohol (beer, wine and hard liquor) on the presence of CAD, but no relationship was found." Dr. Karády added that while no protective effect was detected among light drinkers, as previously thought, no harmful effects were detected either. The researchers are in the process of expanding the study to include more patients and perform further analyses. Independently of whether alcohol has any effect on the coronary arteries, moderate alcohol consumption has been associated with a number of potential side effects, including negative long-term effects on the brain and heart. Co-authors on this study were Balint Szilveszter, M.D., Zsofia D. Drobni, M.D., Marton Kolossvary, M.D., Andrea Bartykowszki, M.D., Mihaly Karolyi, M.D., Ph.D., Adam Jermendy, M.D., Alexisz Panajotu, M.D., Zsolt Bagyura, M.D., and Pal Maurovich-Horvat, M.D., Ph.D., M.P.H. Note: Copies of RSNA 2016 news releases and electronic images will be available online at RSNA.org/press16 beginning Monday, Nov. 28. RSNA is an association of more than 54,000 radiologists, radiation oncologists, medical physicists and related scientists, promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Ill. (RSNA.org)
News Article | November 15, 2016
Marian Schaffer, Principal and Founder of Southeast Discovery, a real estate consulting firm specializing in guiding Baby Boomers with their real estate needs in the niche markets of retirement relocation and second homes in the Southeast region, recently shared 10 reasons to consider the South Carolina lakefront master-planned community of Hampton Lake located near Hilton Head Island, SC and Savannah, GA, for retirement, relocation or second home purchase. “Hampton Lake has been a successfully selling community in general, as well as one that many of our own clients have chosen to purchase in, because it’s a community that appeals to a wide range of buyers and hits on many cylinders of what today’s real estate purchaser is looking for,” said Schaffer. According to Schaffer, these ten qualities make Hampton Lake a strong choice for those seeking a relaxed lakefront community in a Lowcountry setting near beaches and historic Southern towns: #1: Voted Best Facilities and Best Community in the U.S. by the BALA Awards (Best American Living Awards) in 2007 and 2008 In 2007, Hampton Lake won the “Best Facility” BALA award for its Amenity Village which includes the 165-acre lake, The Lake House, The Boat House, Backwater Bill's Restaurant, resort-style pool with lazy river, children’s playground with splash pad, Har-Tru tennis courts, Outpost Campground, state-of-the-art 13,000 SF fitness facility, and full-service spa. In 2008, Hampton Lake won "Best Community in the U.S.,” the crown jewel of the BALA awards, presented annually at the National Association of Home Builders conference. The 165-acre centerpiece lake gives residents the option to boat, kayak or canoe to the community's Amenity Village and other waterfront homes. #2: Hampton Lake has been one of the top selling communities in the coastal Carolinas since its inception in 2006. Selling over 900 properties since 2006, Hampton Lake has now opened up Phase III which includes over 100 new home sites to build on. To date, the Hampton Lake community has over 600 homes built, with close to 100 new homes either under construction or in process with the design review board’s approval. Hampton Lake is located in Bluffton, SC, about 15 minutes west of Hilton Head Island. “Bluffton, SC frequently appears on many ‘best of’ places to live and retire to, including a recent article in Forbes Magazine, which pointed out Bluffton’s scenic waters, warm climate, good state income tax environment, average home price of $197,000, walkability and low crime among the pros of living here,” said Schaffer. “There’s also a brand new high school in Bluffton, for those relocating here with high-school age children. And the charming and historic towns of Savannah, GA and Beaufort, SC are each just 30 minutes away.” #4: Wide variety of home styles, sizes and pricing, appealing to many buyers “At Hampton Lake, there are homes for all stages of life, in prices ranging from the upper $300’s to over $1M. There are Carriage Homes, Cottage Homes, Villas, and Coach Homes, all the way to Estate Homes,” said Schaffer. “This has made Hampton Lake a very popular community as the development appeals to a wide range of buyers and their stages of life.” “People have come from all over the U.S. to live at Hampton Lake. This is a very inclusive community where new residents are welcomed and there are so many social activities, with new ones forming all the time, to get involved with,” said Schaffer. “Monthly events include Meet Your Neighbors, a monthly lecture series, and sunset boat cruises; annual events include a Chili Cook-Off, Super Bowl party; the Blues, Brews & BBQ event; Mardi Gras Jazz Brunch; and the Christmas Boat Parade, to name just a few of the many annual events. Member clubs include the Fishing Club, Golf Club, Canoe and Kayak Club, Billiards Club, Camera Club, and more. There are also book clubs, art groups, the dinner group, movie-goers group, the bridge group, the lunch bunch, and so much more.” “Hampton Lake has one of the best dog parks we have seen,” said Schaffer. “It features a section for small dogs as well as larger dogs. The Hampton Lake dog park is known as the water cooler of the neighborhood, where many start their day with their furry friends and their owners.” The Hampton Lake dues structure is very reasonable at just under $3,500 a year, despite the abundant and award-winning amenities provided. “The fact that there is no golf course at Hampton Lake is actually a plus to many,” said Schaffer. “If you don’t golf, you’re not paying for an amenity you’re not using. This community very wisely took the land that was parceled for a Pete Dye golf course and turned it into a 165-acre lake, because they wanted to provide an amenity for everyone in the community to enjoy, and to offer lakefront properties that so many desire to own.” Schaffer pointed out that Hampton Lake is one of the first fresh water lake communities in the Lowcountry. “Having a lake rather than a golf course helps keeps HOA fees down as maintaining a lake is a lot less expensive than maintaining a golf course. And for golfers, there’s a Pete Dye golf course next door at the sister community, Hampton Hall, as well as many other golf courses around the Bluffton area that are accessible to the public and offer a great golf experience, for an affordable price.” Savannah International Airport (SAV) is just 30 minutes from Hampton Lake and offers 45 non-stop daily departures from a selection of five airlines. Residents of Hampton Lake and the Bluffton area enjoy quality medical care in several directions. Beaufort Memorial Hospital, the largest medical facility between Savannah, GA, and Charleston, S.C. is 35 minutes north, and offers Orthopedics, Cancer Care, Primary Care, Birthing Center, Emergency and other services. Savannah Memorial Hospital, a regional hospital and referral center for cancer care, trauma, rehabilitation, high-risk obstetrics, neonatology, pediatrics and cardiac care, is 30 minutes south. St. Joseph’s Candler Hospital is also 30 minutes south of Bluffton, and offers multiple surgical services, clinical services and imaging services. Hilton Head Island Hospital is 20 minutes east and offers a wide range of services through their Breast Health Center, Heart and Vascular Center, Orthopedic Center, Spine Center and more. If you’re considering relocating to the Southeast but don't know how or where to start your search, we can help. We've been working with clients to find the right area and community to call home in the Southeast for over a decade. Feel free to complete our complimentary online questionnaire here to get feedback on the best areas and specific communities that may be just right for you. About Southeast Discovery Since 2004, Southeast Discovery has been a trusted resource for candid information and insight on communities, developments, and general real estate in the Southeast. Through its highly-ranked web portal, newsletter and blog and its one-on-one work with clients, Southeast Discovery helps buyers actively looking for a retirement or second home in the Southeast navigate the process of identifying the right area and community for their needs. To learn more, visit http://www.southeastdiscovery.com/
News Article | November 16, 2016
ST. PAUL, Minn. & NEW ORLEANS--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced results of the MOMENTUM 3 U.S. IDE Clinical Study during a late-breaking clinical trial session at the American Heart Association (AHA) Scientific Sessions in New Orleans. The MOMENTUM 3 study compared the HeartMate 3™ Left Ventricular Assist System (LVAS) to the HeartMate II™ LVAS in treating advanced stage heart failure and is the largest LVAD trial in the world to evaluate both short-term and long-term patients in a single study. The study results demonstrated patients receiving the HeartMate 3 LVAS had an 86.2 percent survival rate with freedom from disabling stroke and reoperation to repair or replace the device. The MOMENTUM 3 IDE study is a prospective, multi-center, randomized, unblinded, study evaluating the safety and effectiveness of the HeartMate 3 LVAS when used for the treatment of advanced, refractory, left ventricular heart failure. More than 1,000 patients with New York Heart Association (NYHA) Class IIIB or IV heart failure are participating in the study. Patients are being followed for a short-term endpoint of six months, and a long-term endpoint of two years. Current data show the results at the six-month follow-up in the first 294 patients enrolled. The primary endpoint for the study was six months survival with freedom from disabling stroke and reoperation to repair or replace the device. The study met its primary endpoint (non-inferiority P<0.0001; superiority P=0.037). There were no pump thrombosis events reported in patients who were implanted with HeartMate 3 LVAS at six months, confirming the results observed with the HeartMate 3 LVAS in the CE Mark trial. Rates of all other adverse events were similar between the HeartMate 3 LVAS and historical rates seen in the HeartMate II LVAS, which is the most widely used and extensively studied LVAD commercially available. This study included all-comers, which means researchers evaluated the device regardless of whether the patient needed a short-term support option while awaiting transplantation or a long-term support option for those who are not candidates for cardiac transplantation. “The Heartmate 3 LVAS improved clinical outcomes in the MOMENTUM 3 study by avoiding the need for surgical reoperation to replace or remove the pump due to pump thrombosis,” said Dr. Mandeep R. Mehra, medical director of Brigham and Women’s Hospital Heart and Vascular Center in Boston. “More importantly, these clinical gains occurred without an increase in other adverse events, providing important therapeutic progress for our advanced heart failure patients.” The HeartMate 3 LVAS is a small, implantable mechanical circulatory support (MCS) device for advanced heart failure patients who are awaiting transplantation or are not candidates for heart transplantation. It is the first commercially approved (CE marked) LVAD with Full MagLev™ technology, designed to minimize complications and restore blood flow. The HeartMate 3 system utilizes Full MagLev technology, which allows the device’s rotor to be “suspended” by magnetic forces. This design aims to reduce trauma to blood passing through the pump and improve outcomes for patients. “These data in the MOMENTUM 3 study represent the continued advancement in therapy options available for patients living with debilitating heart failure,” said Dr. John B. O’Connell, vice president and medical director for mechanical circulatory support at St. Jude Medical. “The HeartMate II LVAS is an extremely important medical advancement with more than 24,000 implants having occurred to date, and it is the only LVAD approved for both Bridge-to-Transplant and Destination Therapy options in the U.S. The data, now being seen with the HeartMate 3 LVAS, show that we are taking the next steps in advancing medical therapy options.” The HeartMate 3 LVAS is CE Mark approved and limited by federal law to investigational use in the United States. Heart failure is a widespread, chronic condition that develops when the heart muscle weakens and is unable to pump a sufficient amount of blood throughout the body. Heart failure worsens over time and is typically caused by persistent high blood pressure, heart attack, valve disease and other forms of heart disease or birth defects. Left untreated, the lack of adequate blood flow causes the organs to progressively fail, resulting in numerous medical complications that deteriorate a person’s quality of life. According to the American Heart Association (AHA) and the Heart Failure Society of American (HFSA), about 6 million Americans are living with heart failure today, and 670,000 new cases are diagnosed each year. In the United States, the number of deaths from this condition has more than doubled since 1979.1 The HeartMate 3 LVAS includes a centrifugal blood pump that is implanted directly onto a patient's native heart and designed to supplement the pumping ability of the weakened heart's left ventricle, which is responsible for pumping oxygen-rich blood from the lungs throughout the body. The device is implanted above the diaphragm, immediately next to the native heart, and is attached to the aorta (the main artery that feeds blood into the entire body), leaving natural circulation in place while providing all of the energy necessary to propel blood throughout the body. The patient wears an external, wearable controller and battery system that powers the pump. The HeartMate 3 LVAS can pump up to 10 liters of blood per minute. St. Jude Medical is pioneering heart failure disease management with innovative solutions like the CardioMEMS™ HF System, ground-breaking quadripolar technology and, in select European markets, the HeartMate 3™ left ventricular assist system and our first-to-market MultiPoint™ Pacing technology. St. Jude Medical collaborates with heart failure specialists, clinicians and advocacy partners to provide a comprehensive product portfolio that includes innovative, cost-effective solutions that help reduce hospitalizations and improve patient quality of life for heart failure patients around the world. For more information about St. Jude Medical’s focus on heart failure, visit the St. Jude Medical Heart Failure Media Kit or the St. Jude Medical PULSE Blog. Information for patients to learn more about heart failure can be found at www.heartfailureanswers.com. St. Jude Medical is a leading global medical device manufacturer and is dedicated to transforming the treatment of some of the world's most expensive epidemic diseases. The company does this by developing cost-effective medical technologies that save and improve lives of patients around the world. Headquartered in St. Paul, Minn., St. Jude Medical employs approximately 18,000 people worldwide and has five major areas of focus that include heart failure, atrial fibrillation, neuromodulation, traditional cardiac rhythm management and cardiovascular. For more information, please visit sjm.com or follow us on Twitter @SJM_Media. This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. Such forward-looking statements include the expectations, plans and prospects for the company, including potential clinical successes, reimbursement strategies, anticipated regulatory approvals and future product launches, and projected revenues, margins, earnings and market shares. The statements made by the company are based upon management’s current expectations and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include market conditions and other factors beyond the company’s control and the risk factors and other cautionary statements described in the company’s filings with the SEC, including those described in the Risk Factors and Cautionary Statements sections of the company’s Annual Report on Form 10-K for the fiscal year ended January 2, 2016 and Quarterly Report on Form 10-Q for the fiscal quarter ended October 1, 2016. The company does not intend to update these statements and undertakes no duty to any person to provide any such update under any circumstance.
News Article | December 5, 2016
Football at the college-level is associated with increased blood pressure and changes in size, shape, structure and function of the heart, especially among linemen, according to a new study published today in JACC: Cardiovascular Imaging. The study aimed to validate prior observations that football participation led to an increase in blood pressure and an enlarged heart muscle with a primary emphasis on examining the potential health implications of this form of "athlete's heart." "Athlete's heart" is a term to describe the changes seen in the heart of an athlete who engages in high-levels of physical activity. "Our study confirmed associations between football participation, high blood pressure and cardiac remodeling. Importantly, our findings suggest that heart remodeling in this population may have some maladaptive, potentially pathologic qualities," said Aaron L. Baggish, M.D., associate director of the Cardiovascular Performance Program at Massachusetts General Hospital in Boston and the study's senior author. Researchers analyzed data from the Harvard Athlete Initiative, an ongoing research program to address issues relevant to athlete health and exercise physiology. For this study, researchers enrolled first-year athletes to capture their initial season of college-level participation. The study period began at the time of enrollment and lasted for the entire football season--about 90 days. Of 190 eligible football participants enrolled between 2008 and 2014, 87 were included in the study cohort. Athletes who missed more than three days of training for any reason or had echocardiographic images unsuitable for analysis were excluded. The final cohort included 30 linemen and 57 non-linemen. Prior to the season, 57 percent of linemen and 51 percent of non-linemen met the criteria for pre-hypertension. However, after the season 90 percent of linemen met the criteria for pre-hypertension or Stage 1 hypertension while only 49 percent of non-linemen, similar to the preseason, had elevated blood pressure. These changes in blood pressure, particularly among athletes who played at the lineman field positions, were accompanied by thickening of the heart walls and a mild but significant decline in contractile function. Contractile function was measured using strain echocardiography, a relatively new imaging technique that has been shown to predict health outcomes across numerous patient populations. Importantly, the pattern of heart remodeling seen among football lineman differs markedly from the "athletic heart" patterns common among endurance athletes and more closely approximate patterns seen in older populations with overt hypertension and hypertensive heart disease. "While this isn't the first time we've seen that different types of sports participation results in varying forms of cardiac remodeling, this is the first time we've identified an athletic population that appears to remodel with maladaptive attributes," Baggish said. "This type of change to the heart is concerning in this population of young, otherwise healthy athletes and raises questions about long term health implications." Study limitations include that possible confounding factors known to impact blood pressure were not standardized and the duration of the study was relatively brief as many athletes accrue many years of football participation. In an accompanying editorial, William A. Zoghbi, M.D., chairman of the cardiology department at Houston Methodist DeBakey Heart and Vascular Center in Houston, noted the large exclusion of players from the study but said "the findings are important and point to a different cardiac adaptive response in linemen compared to non-linemen. While questions abound, the current investigation has highlighted this unusual adverse cardiac remodeling in sports with the hope of alerting players and their health care professionals, furthering research, and ultimately addressing ways to protect and improve the health of all athletes in team sports." The American College of Cardiology is a 52,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, offers cardiovascular accreditation to hospitals and institutions, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more, visit acc.org. The Journal of the American College of Cardiology is the most widely read cardiovascular journal in the world and is the top ranked cardiovascular journal for its scientific impact. JACC is the flagship for a family of journals that publish peer-reviewed research on all aspects of cardiovascular disease. JACC: Cardiovascular Interventions, JACC: Cardiovascular Imaging and JACC: Heart Failure also rank among the top ten cardiovascular journals for impact. JACC: Clinical Electrophysiology and JACC: Basic Translational Science are the newest journals in the JACC family. Learn more at JACC.org.
Bibevski S.,University of Michigan |
Dunlap M.E.,Heart and Vascular Center
Heart Failure Reviews | Year: 2011
Parasympathetic control of the heart via the vagus nerve is the primary mechanism that regulates beat-to-beat control of heart rate. Additionally, the vagus nerve exerts significant effects at the AV node, as well as effects on both atrial and ventricular myocardium. Vagal control is abnormal in heart failure, occurring at early stages of left ventricular dysfunction, and this reduced vagal function is associated with worse outcomes in patients following myocardial infarction and with heart failure. While central control mechanisms are abnormal, one of the primary sites of attenuated vagal control is at the level of the parasympathetic ganglion. It remains to be seen whether or not preventing or treating abnormal vagal control of the heart improves prognosis. © 2010 Springer Science+Business Media, LLC.